NASDAQ · ALVOW
Alvotech Warrant financials
$0.3799+2.68%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Gross margin | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| Net margin | — | — | — | — |
| Diluted EPS | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — |
| Free cash flow | — | — | — | — |
| Diluted shares | 291.3M | 267.9M | 227.3M | 197.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $172.4M | $51.4M | $11.2M | $66.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.30B | $1.07B | $960.2M | $764.6M |
| Total assets | $1.49B | $1.22B | $950.1M | $828.4M |
| Total liabilities | $1.77B | $1.63B | $1.88B | $1.39B |
| Shareholders' equity | -$284.5M | -$412.8M | -$932.5M | -$564.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology